Literature DB >> 8931116

Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines.

S Tsuji1, S Kawano, H Sawaoka, Y Takei, I Kobayashi, K Nagano, H Fusamoto, T Kamada.   

Abstract

Cyclooxygenase (COX) consists of two isozymes, COX-1 and COX-2. The roles of these isozymes in the gastrointestinal tract are unknown. We investigated messenger RNA expression of the COX-1 and COX-2 genes in the gastrointestinal cancer cell lines MKN28, MKN45, KATO III CACO-2, DLD-1 and LoVo. These cell lines expressed comparable levels of COX-1 mRNA, although their expression of COX-2 varied. Therefore, we studied the effects of NS-398 and indomethacin, specific and non-specific inhibitors for COX-2, on proliferation of the cell lines. Both of the inhibitors suppressed proliferation of the two cell lines that highly expressed COX-2 (MKN45 and CACO-2). However, these inhibitors exerted minimal effects on proliferation of the other cell lines, which expressed significantly lower levels of COX-2. Therefore, it was proposed that COX-2 participates in proliferation of cancer cells because of over expression of the COX-2 gene.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931116     DOI: 10.1016/s0952-3278(96)90095-2

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  21 in total

Review 1.  Current evidence for vitamin D in intestinal function and disease.

Authors:  Mohammadhossein Hassanshahi; Paul H Anderson; Cyan L Sylvester; Andrea M Stringer
Journal:  Exp Biol Med (Maywood)       Date:  2019-07-31

2.  Cyclooxygenase-2 expression correlates with uPAR levels and is responsible for poor prognosis of colorectal cancer.

Authors:  Hiroyuki Konno; Megumi Baba; Tuyoshi Shoji; Manabu Ohta; Shohati Suzuki; Satoshi Nakamura
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

3.  Anti-cancer effect of low dose of celecoxib may be associated with lnc-SCD-1:13 and lnc-PTMS-1:3 but not COX-2 in NCI-N87 cells.

Authors:  Bin Song; Zhen-Bo Shu; Juan Du; Ji-Chen Ren; Ye Feng
Journal:  Oncol Lett       Date:  2017-06-06       Impact factor: 2.967

Review 4.  Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms.

Authors:  Shingo Tsuji; Masahiko Tsujii; Hiroaki Murata; Tsutomu Nishida; Masato Komori; Masakazu Yasumaru; Shuji Ishii; Yoshiaki Sasayama; Sunao Kawano; Norio Hayashi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

5.  Identification of specific genes and pathways involved in NSAIDs-induced apoptosis of human colon cancer cells.

Authors:  Richard-H Huang; Jianyuan Chai; Andrzej-S Tarnawski
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

6.  Growth factor regulation of prostaglandin-endoperoxide synthase 2 (Ptgs2) expression in colonic mesenchymal stem cells.

Authors:  Monica R Walker; Sarah L Brown; Terrence E Riehl; William F Stenson; Thaddeus S Stappenbeck
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

7.  Chemoprevention of gastric cancer by celecoxib in rats.

Authors:  P J Hu; J Yu; Z R Zeng; W K Leung; H L Lin; B D Tang; A H C Bai; J J Y Sung
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

8.  COX-2 is essential for EGF induction of cell proliferation in gastric RGM1 cells.

Authors:  Eiji Sasaki; Kazunari Tominaga; Toshio Watanabe; Yasuhiro Fujiwara; Nobuhide Oshitani; Takayuki Matsumoto; Kazuhide Higuchi; A S Tarnawski; Tetsuo Arakawa
Journal:  Dig Dis Sci       Date:  2003-12       Impact factor: 3.199

Review 9.  Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience.

Authors:  Takashi Fujimura; Tetsuo Ohta; Katsunobu Oyama; Tomoharu Miyashita; Koichi Miwa
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

10.  F-Prostaglandin receptor regulates endothelial cell function via fibroblast growth factor-2.

Authors:  Margaret C Keightley; Pamela Brown; Henry N Jabbour; Kurt J Sales
Journal:  BMC Cell Biol       Date:  2010-01-21       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.